Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 USD | +4.33% |
|
+15.95% | -15.80% |
Jul. 11 | KeyBanc Adjusts Price Target on LifeMD to $10 From $12, Maintains Overweight Rating | MT |
Jul. 01 | LifeMD, Inc.(NasdaqGM:LFMD) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.80% | 295M | |
+40.35% | 9.47B | |
+31.14% | 4.33B | |
-34.24% | 2.49B | |
-6.10% | 1.66B | |
-26.76% | 1.27B | |
-42.98% | 972M | |
-1.14% | 885M | |
-50.69% | 687M | |
-30.79% | 609M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- B. Riley Raises LifeMD's PT to $7 From $3.50 on Increased Conviction for Durable Growth, Enhanced EBITDA; Keeps Buy Rating